Contract HHSN269201800080P
Binding Site, Inc., The · Department Of Health And Human Services · November 15, 2017
Binding Site, Inc., The was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on November 15, 2017 for $9,000 of work in biological product (except diagnostic) manufacturing. Performance is in Bethesda, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 11, 2024.
Contract details
- PIID
- HHSN269201800080P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Bethesda, MD
- First action
- November 15, 2017
- Latest action
- September 11, 2024
Description
DE-OBLIGATION OF FUNDING.
Modification timeline
-
September 11, 2024Mod P00001$-8
-
November 15, 2017Base awardBINDING SITE INC:1107067 [18-001982]$9.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN269201800080P?
Contract HHSN269201800080P is a federal contract awarded to Binding Site, Inc., The by Department Of Health And Human Services on November 15, 2017 for $9,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract HHSN269201800080P?
Binding Site, Inc., The won contract HHSN269201800080P from Department Of Health And Human Services.
How much is contract HHSN269201800080P worth?
Contract HHSN269201800080P has obligated $9,000 to date.